Hermon Antifungal .soap. Soap
NDC 85398-025
Product Information
Hermon Antifungal .soap. (tolnaftate 1%) is a OTC MONOGRAPH DRUG-approved product labeled by Beautivity Llc. Tolnaftate is used to treat skin infections such as athlete's foot, jock itch, and ringworm. It is supplied as a soap for topical administration. This product entry covers the primary NDC 85398-025 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 85398-025?
What are the uses of this product?
What are Active Ingredients of this product?
- TOLNAFTATE 10 mg/g - A synthetic antifungal agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLNAFTATE (UNII: 06KB629TKV)
- TOLNAFTATE (UNII: 06KB629TKV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- AQUA (UNII: 059QF0KO0R)
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL (UNII: VIF565UC2G)
- SORBITOL (UNII: 506T60A25R)
- COCOS NUCIFERA (COCONUT) OIL (UNII: Q9L0O73W7L)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- GLYCERIN (UNII: PDC6A3C0OX)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- LAURIC ACID (UNII: 1160N9NU9U)
- SODIUM GLUTAMATE (UNII: W81N5U6R6U)
- BUTYROSPERMUM PARKII (SHEA) BUTTER (UNII: K49155WL9Y)
- ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
- SUCROSE (UNII: C151H8M554)
- SODIUM PALMITATE (UNII: JQ43KP6296)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1807715 - tolnaftate 1 % Medicated Bar Soap
- RxCUI: 1807715 - tolnaftate 0.01 MG/MG Medicated Bar Soap
* Please review the full disclaimer at the bottom of this page.